Advanced KRAS G12D Mutant Solid Tumors
3 clinical trials · Condition
◉ Watch Advanced KRAS G12D Mutant Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations (NCT07134998) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-16 |
| A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385678) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-05 |
| Phase I Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT05533463) | Jiangsu HengRui Medicine Co., Ltd. | 2022-09-21 |
Track Advanced KRAS G12D Mutant Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.